With latest FDA nod, Biohaven's Nurtec becomes first migraine med to prevent—and treat—attacks

Retrieved on: 2021-05-27 20:37:30

Tags for this article:

Click the tags to see associated articles and topics

With latest FDA nod, Biohaven's Nurtec becomes first migraine med to prevent—and treat—attacks. View article details on hiswai:

Excerpt

Meanwhile, injectable monoclonal antibodies such as Amgen's Aimovig, Eli Lilly's Emgality and Teva Pharmaceuticals' Ajovy have been approved in ...

Article found on: www.fiercepharma.com